Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Tetraphase Pharmaceuticals Inc. TTPH

Healthcare Biotechnology
Tetraphase Pharmaceuticals Inc is a biopharmaceutical company using its proprietary chemistry technology to create, develop and commercialize novel tetracyclines for serious and life-threatening conditions, including bacterial infections caused by multidrug-resistant, or MDR, bacteria.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:TTPH)

La Jolla Pharmaceutical Company Announces the Closing of Acquisition of Tetraphase Pharmaceuticals, Inc.

GlobeNewswire July 28, 2020

La Jolla Pharmaceutical Company to Acquire Tetraphase Pharmaceuticals, Inc.

GlobeNewswire June 24, 2020

Tetraphase Announces Receipt of Proposal from La Jolla Pharmaceutical Company, Determination of Superior Offer and Notice to Melinta

Business Wire June 22, 2020

Melinta Therapeutics to Acquire Tetraphase Pharmaceuticals

Business Wire June 4, 2020

AcelRx Pharmaceuticals Announces It Will Not Further Revise Its Offer to Acquire Tetraphase

PR Newswire June 3, 2020

Tetraphase Announces Receipt of Amended Melinta Proposal, Determination of Superior Offer and Notice to AcelRx

Business Wire June 1, 2020

Tetraphase Announces Second Amendment to Merger Agreement with AcelRx Pharmaceuticals for Increased Consideration

Business Wire May 29, 2020

Tetraphase Announces Receipt of Amended Melinta Proposal, Determination of Superior Offer and Notice to AcelRx

Business Wire May 27, 2020

AcelRx Pharmaceuticals Announces Revised Merger Agreement with Tetraphase

PR Newswire May 27, 2020
View More News ››

Opinion & Analysis (NDAQ:TTPH)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:TTPH)

TTPH.said to be 7.00

dollars nextweek
Trader24 - September 21, 2015

got in at 9.00

good call guys.
Trader24 - September 18, 2015

time to load up.

</this has been a certain setback for the company and its shares, however, there may exist an opportunity hidden behind the negative...
Trader24 - September 10, 2015
View more Bullboard ››

Majestic Gold Corp.

Majestic Gold Corp.

Majestic Gold Corp. is engaged in mineral resource exploration, development and extraction. It operates the Songjiagou open ...
View More »